Equillium (EQ) Short-term Investments (2018 - 2024)
Equillium (EQ) reported Short-term Investments of $4.5 million for Q4 2024, down 74.56% year-over-year from $17.6 million in Q1 2024, and down 56.95% quarter-over-quarter from $10.4 million in Q3 2024.
Equillium (EQ) Short-term Investments (2018 - 2024) Analysis & Trends
Equillium (EQ) has 7 years of Short-term Investments data on file, last reported at $4.5 million in Q4 2024.
- Short-term Investments for Q4 2024 came in at $4.5 million, down 74.56% year-over-year; the trailing twelve-month figure through Dec 2024 was $4.5 million (down 74.56% YoY), and the FY2024 annual result was $4.5 million, down 74.56% from the prior year.
- Short-term Investments eased to $4.5 million in Q4 2024 per EQ's latest filing, from $10.4 million in the prior quarter.
- Over five years, Short-term Investments peaked at $58.2 million in Q4 2020 and troughed at $4.5 million in Q4 2024.
- A 5-year average of $26.1 million and a median of $22.5 million in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2021 and 2024: Short-term Investments surged 96.66% in 2021, then tumbled 74.56% in 2024.
- A 5-year view of Short-term Investments shows it stood at $58.2 million in 2020, then plunged by 47.84% to $30.3 million in 2021, then tumbled by 60.73% to $11.9 million in 2022, then soared by 48.12% to $17.6 million in 2023, then plunged by 74.56% to $4.5 million in 2024.
- Business Quant data shows EQ's Short-term Investments at $4.5 million in Q4 2024, $10.4 million in Q3 2024, and $22.2 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 10.43 Mn |
| Jun 30, 2024 | 22.24 Mn |
| Mar 31, 2024 | 20.72 Mn |
| Dec 31, 2023 | 17.65 Mn |
| Sep 30, 2023 | 11.92 Mn |
| Jun 30, 2023 | 22.75 Mn |
| Mar 31, 2023 | 37.49 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 18.79 Mn |
| Jun 30, 2022 | 33.75 Mn |
| Mar 31, 2022 | 42.58 Mn |
| Dec 31, 2021 | 30.35 Mn |
| Sep 30, 2021 | 13.54 Mn |
| Jun 30, 2021 | 24.12 Mn |
| Mar 31, 2021 | 53.22 Mn |
| Dec 31, 2020 | 58.18 Mn |
| Sep 30, 2020 | 41.29 Mn |
| Jun 30, 2020 | 18.52 Mn |
| Mar 31, 2020 | 27.06 Mn |